Gilead Announces Share Repurchase Program
January 29 2010 - 8:30AM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the
company’s Board of Directors has authorized the repurchase of up to
$1.0 billion of the company’s common stock through January
2011.
Purchases may be made in the open market or in privately
negotiated transactions from time to time, as determined by
Gilead’s management and in accordance with the requirements of the
Securities and Exchange Commission.
The timing and actual number of shares repurchased will depend
on a variety of factors including price, corporate and regulatory
requirements and other market conditions.
About Gilead
Sciences
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
This press release includes forward-looking statements, within
the meaning of the Private Securities Litigation Reform Act of
1995, that are subject to risks, uncertainties and other factors,
including our ability to consummate a share repurchase program due
to changes in our stock price, corporate or other market
conditions. The reader is cautioned not to rely on these
forward-looking statements. These and other risks are described in
detail in Gilead’s Quarterly Reports on Form 10-Q for quarter ended
September 30, 2009 as filed with the U.S. Securities and Exchange
Commission. All forward-looking statements are based on information
currently available to Gilead and Gilead assumes no obligation to
update any such forward-looking statements.
For more information on Gilead
Sciences, please visit the company's website at www.gilead.comor
call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024